Anna S Nordvig1, Kathryn T Fong1, Joshua Z Willey1, Kiran T Thakur1, Amelia K Boehme1, Wendy S Vargas1, Craig J Smith1, Mitchell S V Elkind1. 1. Department of Neurology (ASN, KTF, JZW, KTT, AKB, WSV, MSVE), Vagelos College of Physicians and Surgeons, Columbia University and the New York Presbyterian Hospital; Department of Epidemiology (AKB, MSVE), Mailman School of Public Health, Columbia University, New York, NY; Division of Cardiovascular Sciences (CJS), Lydia Becker Institute of Immunology and Inflammation, University of Manchester; and Manchester Centre for Clinical Neurosciences (CJS), Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, United Kingdom.
Abstract
PURPOSE OF REVIEW: Neurologic complications are increasingly recognized in the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This coronavirus is related to severe acute respiratory syndrome coronavirus (SARS-CoV) and other human coronavirus-related illnesses that are associated with neurologic symptoms. These symptoms raise the question of a neuroinvasive potential of SARS-CoV-2. RECENT FINDINGS: Potential neurologic symptoms and syndromes of SARS-CoV-2 include headache, fatigue, dizziness, anosmia, ageusia, anorexia, myalgias, meningoencephalitis, hemorrhage, altered consciousness, Guillain-Barré syndrome, syncope, seizure, and stroke. In addition, we discuss neurologic effects of other coronaviruses, special considerations for management of neurologic patients, and possible long-term neurologic and public health sequelae. SUMMARY: As SARS-CoV-2 is projected to infect a large part of the world's population, understanding the potential neurologic implications of COVID-19 will help neurologists and others recognize and intervene in neurologic morbidity during and after the pandemic of 2020.
PURPOSE OF REVIEW: Neurologic complications are increasingly recognized in the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This coronavirus is related to severe acute respiratory syndrome coronavirus (SARS-CoV) and other human coronavirus-related illnesses that are associated with neurologic symptoms. These symptoms raise the question of a neuroinvasive potential of SARS-CoV-2. RECENT FINDINGS: Potential neurologic symptoms and syndromes of SARS-CoV-2 include headache, fatigue, dizziness, anosmia, ageusia, anorexia, myalgias, meningoencephalitis, hemorrhage, altered consciousness, Guillain-Barré syndrome, syncope, seizure, and stroke. In addition, we discuss neurologic effects of other coronaviruses, special considerations for management of neurologic patients, and possible long-term neurologic and public health sequelae. SUMMARY: As SARS-CoV-2 is projected to infect a large part of the world's population, understanding the potential neurologic implications of COVID-19 will help neurologists and others recognize and intervene in neurologic morbidity during and after the pandemic of 2020.
Authors: Paul B McCray; Lecia Pewe; Christine Wohlford-Lenane; Melissa Hickey; Lori Manzel; Lei Shi; Jason Netland; Hong Peng Jia; Carmen Halabi; Curt D Sigmund; David K Meyerholz; Patricia Kirby; Dwight C Look; Stanley Perlman Journal: J Virol Date: 2006-11-01 Impact factor: 5.103
Authors: Fina Lovren; Yi Pan; Adrian Quan; Hwee Teoh; Guilin Wang; Praphulla C Shukla; Kevin S Levitt; Gavin Y Oudit; Mohammed Al-Omran; Duncan J Stewart; Arthur S Slutsky; Mark D Peterson; Peter H Backx; Josef M Penninger; Subodh Verma Journal: Am J Physiol Heart Circ Physiol Date: 2008-07-25 Impact factor: 4.733
Authors: Ruth Elliott; Fan Li; Isabelle Dragomir; Ming Ming W Chua; Brian D Gregory; Susan R Weiss Journal: PLoS One Date: 2013-09-18 Impact factor: 3.240
Authors: Kun Li; Christine Wohlford-Lenane; Stanley Perlman; Jincun Zhao; Alexander K Jewell; Leah R Reznikov; Katherine N Gibson-Corley; David K Meyerholz; Paul B McCray Journal: J Infect Dis Date: 2015-10-20 Impact factor: 5.226
Authors: Amirhossein Roshanshad; Mohammad Ali Ashraf; Romina Roshanshad; Ali Kharmandar; Seyed Alireza Zomorodian; Hossein Ashraf Journal: J Ophthalmic Vis Res Date: 2021-04-29
Authors: Carmen García-Sánchez; Marco Calabria; Nicholas Grunden; Catalina Pons; Juan Antonio Arroyo; Beatriz Gómez-Anson; Alberto Lleó; Daniel Alcolea; Roberto Belvís; Noemí Morollón; Isabel Mur; Virginia Pomar; Pere Domingo Journal: Brain Behav Date: 2022-02-08 Impact factor: 2.708